Electromed (ELMD) EBITDA (2010 - 2026)

Electromed (ELMD) has 17 years of EBITDA data on file, last reported at $3.8 million in Q1 2026.

• On a quarterly basis, EBITDA rose 75.98% year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $13.1 million, a 46.24% increase from a year earlier, with the FY2025 full-year figure at $9.7 million, up 46.79% from the prior year.
• EBITDA for Q1 2026 stood at $3.8 million, up from $3.6 million in the prior quarter.
• Over the last five years, EBITDA for ELMD reached as high as $3.8 million in Q1 2026 and fell as low as $44000.0 in Q3 2022.
• Historically, EBITDA has averaged $1.9 million across 5 years, with a median of $1.9 million in 2024.
• Across the five-year window, EBITDA slumped 91.82% in 2022 and surged 1264.79% in 2024, its largest moves.
• Year by year, EBITDA stood at $1.3 million in 2022, then soared by 77.63% to $2.3 million in 2023, then gained by 12.33% to $2.5 million in 2024, then surged by 42.41% to $3.6 million in 2025, then rose by 4.03% to $3.8 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $3.8 million in Q1 2026, $3.6 million in Q4 2025, and $2.7 million in Q3 2025.